Depakote

Since 1983, doctors have prescribed Depakote in the United States to treat patients with epilepsy.  Approximately two million Americans have some form of epilepsy, and 125,000 new cases of epilepsy are reported each year. Abbott Laboratories, who manufactures Depakote, known as divalproex or valproic acid is also prescribed as a mood stabilizer for patients diagnosed with bipolar disorder.  Doctors also prescribe Depakote to patients who suffer from migraines.

Depakote extended release tablets, known as Depakote ER, should be swallowed whole once daily with or without food. The tablets should not be crushed or chewed. Depakote ER is available in tablet form in two different dosage strengths so that your doctor can choose the appropriate strength for each patient.

Why Prescribed

Depakote tablets are administered orally for bipolar disorder, specifically mania. The recommended initial dose is 750 mg daily in divided doses. The dose should be increased as rapidly as possible to achieve the lowest therapeutic dose which produces the desired clinical effect.

Patients suffering from epilepsy should initiate therapy at 10 to 15 mg/kg/day. The dosage should be increased by 5 to 10 mg/kg/week to achieve optimal clinical response. Ordinarily, optimal clinical response is achieved at daily doses below 60 mg/kg/day.

Doctors prescribe Depakote tablets orally for treatment of migraine headaches in adults. The recommended starting dose is 250 mg twice daily. Some patients may benefit from doses up to 1000 mg/day.

^ Back To Top

FDA Approved Uses

In 1995, the FDA approved Depakote® ER for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. The FDA first approved Depakote for treating seizures in adults and children 10 years of age or older.  Later, the FDA approved Depakote for use in treating migraine headaches in adults.

^ Back To Top

Side Effects

Some of the side effects you may experience with Depakote ER are drowsiness, nausea, abdominal pain, diarrhea, vomiting, low platelet count, tremors, tiredness, and hair loss.

^ Back To Top

Warnings and Alerts

Doctors should check liver function in patients before prescribing this medication.  Notify your doctor immediately if you develop malaise (illness), weakness, tiredness, facial swelling, loss of appetite or vomiting.  Doctors are also urged to monitor Depakote users for symptoms that lead to liver toxicity.

^ Back To Top

Drug Contraindications

Valproate products should not be prescribed to patients with hepatic disease or significant hepatic dysfunction – liver disease. Hepatic failure resulting in fatalities has occurred in patients receiving valproic acid and its derivatives, usually during the first six months of treatment.  Pregnant women should refrain from using Depakote as valproate may produce teratogenic effects in the offspring of women receiving the drug during pregnancy.

^ Back To Top

FAQ's

What should I avoid while taking Depakote?

Patients should avoid drinking alcohol while taking Depakote because it can increase the effects of alcohol and lead to significant drowsiness.  Alcohol consumption while taking Depakote may also increase your risk of developing liver problems.  Also, avoid using illegal drugs while taking Depakote because they may counteract Depakote’s effect and increase your risk of developing seizures. As Depakote may cause drowsiness, make sure you know how it will affect you before you begin driving or operating any machinery.

Does Depakote cause birth defects?

The FDA released reports concluding that the use of Depakote (valproic acid) during the first trimester of pregnancy has been associated with an increased risk of spinal cord defects (e.g., spina bifida) in the fetus. Bleeding and liver problems, as well as other birth defects have been reported too. If you are already pregnant and on valproic acid, call your doctor immediately to discuss your options as quickly stopping valproic acid may lead to harmful effects such as seizures.

^ Back To Top